 Simona Zarini
Concepts (350)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Resistance | 10 | 2024 | 1198 | 1.770 |
Why?
| | Eicosanoids | 8 | 2018 | 62 | 1.220 |
Why?
| | Leukotrienes | 10 | 2012 | 37 | 1.160 |
Why?
| | Diabetes Mellitus, Type 2 | 8 | 2024 | 2521 | 0.920 |
Why?
| | 1-Acylglycerophosphocholine O-Acyltransferase | 3 | 2014 | 5 | 0.600 |
Why?
| | Mass Spectrometry | 5 | 2019 | 741 | 0.580 |
Why?
| | Neutrophils | 15 | 2017 | 1238 | 0.560 |
Why?
| | Arachidonic Acid | 6 | 2017 | 120 | 0.550 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 5 | 2019 | 180 | 0.550 |
Why?
| | Muscle, Skeletal | 6 | 2024 | 1701 | 0.510 |
Why?
| | Triglycerides | 3 | 2024 | 525 | 0.500 |
Why?
| | Ceramides | 4 | 2024 | 118 | 0.500 |
Why?
| | Arachidonate 5-Lipoxygenase | 9 | 2017 | 43 | 0.490 |
Why?
| | Lipid Metabolism | 1 | 2019 | 511 | 0.470 |
Why?
| | Sphingolipids | 3 | 2024 | 77 | 0.440 |
Why?
| | Obesity | 10 | 2024 | 2974 | 0.430 |
Why?
| | Myeloid Cells | 1 | 2014 | 146 | 0.410 |
Why?
| | Metabolomics | 1 | 2019 | 679 | 0.410 |
Why?
| | Cysteine | 5 | 2011 | 206 | 0.400 |
Why?
| | Dinoprostone | 6 | 2022 | 191 | 0.370 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2024 | 216 | 0.370 |
Why?
| | Leukotriene B4 | 9 | 2012 | 42 | 0.360 |
Why?
| | Adipose Tissue | 3 | 2025 | 624 | 0.320 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2019 | 194 | 0.320 |
Why?
| | Peritonitis | 1 | 2009 | 84 | 0.300 |
Why?
| | Diabetic Retinopathy | 3 | 2019 | 189 | 0.290 |
Why?
| | Retina | 5 | 2019 | 298 | 0.290 |
Why?
| | Bone Marrow | 1 | 2009 | 286 | 0.280 |
Why?
| | Phospholipids | 5 | 2018 | 223 | 0.280 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 3 | 2006 | 56 | 0.280 |
Why?
| | Lipids | 2 | 2024 | 664 | 0.270 |
Why?
| | Cell Communication | 1 | 2009 | 313 | 0.270 |
Why?
| | Sarcolemma | 2 | 2024 | 41 | 0.270 |
Why?
| | Diglycerides | 2 | 2024 | 61 | 0.260 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2006 | 152 | 0.250 |
Why?
| | Insulin | 3 | 2025 | 2398 | 0.240 |
Why?
| | Macrophages | 5 | 2020 | 1548 | 0.230 |
Why?
| | Paracrine Communication | 1 | 2025 | 65 | 0.230 |
Why?
| | Calcimycin | 5 | 2014 | 49 | 0.230 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 91 | 0.220 |
Why?
| | Phosphatidylcholines | 1 | 2024 | 148 | 0.210 |
Why?
| | Hyperinsulinism | 1 | 2024 | 121 | 0.210 |
Why?
| | Animals | 30 | 2024 | 37011 | 0.200 |
Why?
| | Mitochondrial Diseases | 1 | 2023 | 92 | 0.200 |
Why?
| | Arachidonic Acids | 1 | 2003 | 62 | 0.200 |
Why?
| | Pancreas | 1 | 2025 | 328 | 0.200 |
Why?
| | Mice | 21 | 2024 | 17843 | 0.200 |
Why?
| | Leukotriene A4 | 7 | 2009 | 11 | 0.190 |
Why?
| | Antioxidants | 2 | 2002 | 577 | 0.180 |
Why?
| | Glutathione | 1 | 2002 | 358 | 0.170 |
Why?
| | Leukotriene Antagonists | 2 | 2019 | 43 | 0.170 |
Why?
| | Lipolysis | 1 | 2020 | 44 | 0.160 |
Why?
| | Diabetic Neuropathies | 1 | 2021 | 94 | 0.160 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 433 | 0.160 |
Why?
| | Acetates | 1 | 2019 | 100 | 0.150 |
Why?
| | Myofibroblasts | 1 | 2020 | 125 | 0.150 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1458 | 0.150 |
Why?
| | Receptors, Leukotriene | 2 | 2011 | 14 | 0.150 |
Why?
| | Humans | 35 | 2025 | 137514 | 0.150 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5427 | 0.140 |
Why?
| | Glucose Clamp Technique | 3 | 2024 | 194 | 0.140 |
Why?
| | Quinolines | 1 | 2019 | 180 | 0.140 |
Why?
| | Subcutaneous Fat | 3 | 2025 | 80 | 0.140 |
Why?
| | Calcium Ionophores | 2 | 2014 | 3 | 0.140 |
Why?
| | Receptors, Prostaglandin E, EP2 Subtype | 1 | 2017 | 6 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 4 | 2024 | 533 | 0.140 |
Why?
| | Hydroxyeicosatetraenoic Acids | 3 | 2011 | 43 | 0.130 |
Why?
| | Endocannabinoids | 1 | 2017 | 63 | 0.130 |
Why?
| | Lysophospholipids | 2 | 2014 | 80 | 0.120 |
Why?
| | Phenotype | 1 | 2024 | 3205 | 0.120 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 363 | 0.120 |
Why?
| | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2014 | 5 | 0.120 |
Why?
| | Ependymoglial Cells | 1 | 2014 | 8 | 0.120 |
Why?
| | Intestinal Neoplasms | 1 | 2014 | 31 | 0.110 |
Why?
| | Group IV Phospholipases A2 | 3 | 2014 | 47 | 0.110 |
Why?
| | Inflammation | 6 | 2019 | 2837 | 0.110 |
Why?
| | Bone Marrow Cells | 3 | 2017 | 313 | 0.110 |
Why?
| | CD40 Antigens | 1 | 2014 | 89 | 0.110 |
Why?
| | Linoleoyl-CoA Desaturase | 1 | 2013 | 3 | 0.110 |
Why?
| | Rats | 6 | 2024 | 5676 | 0.110 |
Why?
| | Cell Membrane | 2 | 2007 | 751 | 0.110 |
Why?
| | Athletes | 3 | 2024 | 406 | 0.110 |
Why?
| | Inflammation Mediators | 3 | 2009 | 514 | 0.100 |
Why?
| | Prostaglandins | 3 | 2011 | 97 | 0.100 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2013 | 98 | 0.100 |
Why?
| | Exercise | 1 | 2024 | 2024 | 0.100 |
Why?
| | Cytosol | 2 | 2020 | 227 | 0.100 |
Why?
| | Mice, Inbred C57BL | 9 | 2023 | 5792 | 0.100 |
Why?
| | Models, Animal | 1 | 2014 | 387 | 0.100 |
Why?
| | Chromatography, High Pressure Liquid | 5 | 2018 | 595 | 0.100 |
Why?
| | Interleukin-13 | 2 | 2022 | 149 | 0.100 |
Why?
| | Retinal Degeneration | 1 | 2012 | 38 | 0.100 |
Why?
| | Safflower Oil | 1 | 2012 | 5 | 0.100 |
Why?
| | Culture Media, Conditioned | 2 | 2022 | 111 | 0.100 |
Why?
| | Mice, Transgenic | 4 | 2012 | 2182 | 0.090 |
Why?
| | Linoleic Acid | 1 | 2012 | 44 | 0.090 |
Why?
| | Glutathione Transferase | 3 | 2002 | 104 | 0.090 |
Why?
| | Retinal Neovascularization | 1 | 2011 | 25 | 0.090 |
Why?
| | Cells, Cultured | 9 | 2017 | 4206 | 0.090 |
Why?
| | Intestinal Mucosa | 2 | 2014 | 621 | 0.090 |
Why?
| | Colitis | 1 | 2014 | 265 | 0.090 |
Why?
| | Cardiolipins | 1 | 2012 | 85 | 0.090 |
Why?
| | Papilledema | 1 | 2011 | 39 | 0.090 |
Why?
| | Intestines | 2 | 2014 | 359 | 0.090 |
Why?
| | Phosphatidylglycerols | 1 | 2011 | 24 | 0.090 |
Why?
| | Leukocytes | 1 | 2012 | 311 | 0.090 |
Why?
| | Retinal Diseases | 1 | 2011 | 91 | 0.090 |
Why?
| | Phospholipases A2, Cytosolic | 1 | 2010 | 7 | 0.090 |
Why?
| | Mycoplasma pneumoniae | 1 | 2011 | 56 | 0.090 |
Why?
| | Lipoxygenase | 2 | 2017 | 18 | 0.080 |
Why?
| | Leukotriene C4 | 3 | 2012 | 11 | 0.080 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2011 | 56 | 0.080 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2010 | 79 | 0.080 |
Why?
| | Bone Marrow Transplantation | 2 | 2009 | 286 | 0.080 |
Why?
| | Shock, Hemorrhagic | 1 | 2012 | 168 | 0.080 |
Why?
| | Pulmonary Surfactants | 1 | 2011 | 106 | 0.080 |
Why?
| | Ionophores | 3 | 2006 | 24 | 0.080 |
Why?
| | Thimerosal | 2 | 2008 | 6 | 0.080 |
Why?
| | Neuroglia | 2 | 2009 | 172 | 0.080 |
Why?
| | Retinal Vessels | 3 | 2019 | 69 | 0.080 |
Why?
| | Zebrafish | 1 | 2014 | 496 | 0.080 |
Why?
| | Oxidation-Reduction | 2 | 2024 | 1059 | 0.080 |
Why?
| | Synovial Membrane | 1 | 2010 | 117 | 0.080 |
Why?
| | Chemotaxis, Leukocyte | 3 | 2004 | 138 | 0.080 |
Why?
| | Zymosan | 1 | 2009 | 65 | 0.080 |
Why?
| | Heart Failure | 2 | 2013 | 2222 | 0.080 |
Why?
| | Endothelial Cells | 1 | 2014 | 780 | 0.080 |
Why?
| | Acute Lung Injury | 1 | 2012 | 288 | 0.080 |
Why?
| | Arthritis, Experimental | 1 | 2010 | 147 | 0.080 |
Why?
| | Enzymes | 1 | 2009 | 67 | 0.080 |
Why?
| | Mice, Knockout | 6 | 2014 | 3020 | 0.080 |
Why?
| | Calcium | 2 | 2006 | 1233 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2022 | 1242 | 0.070 |
Why?
| | Mitochondria | 2 | 2012 | 947 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 1 | 2009 | 182 | 0.070 |
Why?
| | Lysophosphatidylcholines | 1 | 2007 | 22 | 0.070 |
Why?
| | Middle Aged | 7 | 2025 | 33355 | 0.070 |
Why?
| | Macrophages, Alveolar | 1 | 2011 | 392 | 0.070 |
Why?
| | Male | 11 | 2025 | 67718 | 0.070 |
Why?
| | Adult | 8 | 2025 | 37821 | 0.070 |
Why?
| | Pyrazoles | 1 | 2010 | 427 | 0.070 |
Why?
| | Adenosine Triphosphatases | 1 | 2007 | 167 | 0.070 |
Why?
| | Sulfonamides | 1 | 2010 | 513 | 0.060 |
Why?
| | Blotting, Western | 4 | 2012 | 1227 | 0.060 |
Why?
| | Thromboxanes | 1 | 2005 | 17 | 0.060 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2005 | 8 | 0.060 |
Why?
| | Isoprostanes | 1 | 2005 | 15 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2755 | 0.060 |
Why?
| | Hyperglycemia | 1 | 2009 | 346 | 0.060 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2006 | 134 | 0.060 |
Why?
| | Phospholipases A | 1 | 2006 | 102 | 0.060 |
Why?
| | Capillary Permeability | 2 | 2019 | 144 | 0.060 |
Why?
| | Fibroblasts | 1 | 2010 | 990 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2013 | 4295 | 0.060 |
Why?
| | Female | 10 | 2025 | 73162 | 0.060 |
Why?
| | Bacterial Proteins | 1 | 2011 | 889 | 0.060 |
Why?
| | SRS-A | 1 | 2004 | 31 | 0.060 |
Why?
| | Receptors, IgE | 1 | 2004 | 45 | 0.060 |
Why?
| | Protein C | 1 | 2004 | 59 | 0.050 |
Why?
| | Enzyme Activation | 1 | 2006 | 816 | 0.050 |
Why?
| | Ubiquinone | 1 | 2023 | 30 | 0.050 |
Why?
| | Carnitine | 1 | 2024 | 83 | 0.050 |
Why?
| | Brain Edema | 1 | 2004 | 61 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2007 | 404 | 0.050 |
Why?
| | Electron Transport | 1 | 2023 | 115 | 0.050 |
Why?
| | Membrane Proteins | 3 | 2008 | 1167 | 0.050 |
Why?
| | Bronchial Hyperreactivity | 1 | 2004 | 111 | 0.050 |
Why?
| | Rats, Inbred SHR | 2 | 2013 | 45 | 0.050 |
Why?
| | Subcellular Fractions | 1 | 2003 | 82 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Chromatography, Gel | 1 | 2003 | 127 | 0.050 |
Why?
| | Saccharomyces cerevisiae | 1 | 2007 | 562 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 22 | 0.050 |
Why?
| | Mast Cells | 1 | 2004 | 146 | 0.050 |
Why?
| | Mice, Inbred ICR | 1 | 2003 | 120 | 0.050 |
Why?
| | Adjuvants, Immunologic | 1 | 2004 | 226 | 0.050 |
Why?
| | Sodium | 1 | 2004 | 218 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 49 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 86 | 0.050 |
Why?
| | Glucose | 2 | 2022 | 1018 | 0.050 |
Why?
| | Encephalitis | 1 | 2004 | 137 | 0.050 |
Why?
| | Superoxides | 2 | 2019 | 202 | 0.050 |
Why?
| | Lipoxygenase Inhibitors | 3 | 2012 | 38 | 0.050 |
Why?
| | Vasodilation | 1 | 2025 | 494 | 0.050 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2002 | 158 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 269 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 2066 | 0.050 |
Why?
| | Acute Disease | 1 | 2024 | 1008 | 0.040 |
Why?
| | Prostaglandins E, Synthetic | 1 | 2000 | 2 | 0.040 |
Why?
| | Molecular Structure | 1 | 2002 | 508 | 0.040 |
Why?
| | Peroxidases | 1 | 2000 | 34 | 0.040 |
Why?
| | Allergens | 1 | 2004 | 407 | 0.040 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 77 | 0.040 |
Why?
| | Lung Diseases, Obstructive | 1 | 2000 | 50 | 0.040 |
Why?
| | Bronchitis | 1 | 2000 | 44 | 0.040 |
Why?
| | Vitamin E | 1 | 2001 | 122 | 0.040 |
Why?
| | Myocardium | 2 | 2013 | 1004 | 0.040 |
Why?
| | Organotin Compounds | 1 | 2000 | 4 | 0.040 |
Why?
| | Substrate Specificity | 3 | 2008 | 385 | 0.040 |
Why?
| | Serine | 1 | 2021 | 141 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2004 | 599 | 0.040 |
Why?
| | Muscle, Smooth | 1 | 2000 | 162 | 0.040 |
Why?
| | Plant Oils | 1 | 1999 | 32 | 0.040 |
Why?
| | Electroretinography | 1 | 2019 | 48 | 0.040 |
Why?
| | Cyclopropanes | 1 | 2019 | 90 | 0.040 |
Why?
| | Food Handling | 1 | 1999 | 60 | 0.040 |
Why?
| | Mitochondria, Muscle | 1 | 2020 | 116 | 0.040 |
Why?
| | Weight Loss | 1 | 2024 | 770 | 0.040 |
Why?
| | Physical Endurance | 1 | 2020 | 275 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2025 | 803 | 0.040 |
Why?
| | Time Factors | 2 | 2008 | 6817 | 0.040 |
Why?
| | Dietary Fats | 1 | 2020 | 301 | 0.040 |
Why?
| | Sulfides | 1 | 2019 | 99 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2615 | 0.040 |
Why?
| | Phenols | 1 | 1999 | 101 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 974 | 0.040 |
Why?
| | Indoles | 3 | 2012 | 415 | 0.040 |
Why?
| | Adipocytes | 1 | 2020 | 215 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 172 | 0.040 |
Why?
| | Neurons | 1 | 2007 | 1613 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 778 | 0.040 |
Why?
| | Endoplasmic Reticulum | 1 | 2020 | 265 | 0.040 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2019 | 159 | 0.040 |
Why?
| | Endothelium, Vascular | 3 | 2011 | 923 | 0.040 |
Why?
| | Gene Expression Profiling | 2 | 2019 | 1770 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2018 | 50 | 0.040 |
Why?
| | Lung Diseases | 1 | 2004 | 768 | 0.040 |
Why?
| | Hypersensitivity | 1 | 2001 | 256 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2020 | 615 | 0.030 |
Why?
| | Glycerol | 1 | 2017 | 94 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2000 | 963 | 0.030 |
Why?
| | Cyclic AMP | 1 | 2017 | 243 | 0.030 |
Why?
| | Immunoblotting | 1 | 2017 | 307 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2014 | 1324 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 451 | 0.030 |
Why?
| | Body Mass Index | 1 | 2024 | 2369 | 0.030 |
Why?
| | Cyclooxygenase 2 | 2 | 2011 | 178 | 0.030 |
Why?
| | Cytokines | 2 | 2014 | 2095 | 0.030 |
Why?
| | Skin | 1 | 2020 | 751 | 0.030 |
Why?
| | Prostaglandin-E Synthases | 1 | 2014 | 6 | 0.030 |
Why?
| | Signal Transduction | 3 | 2017 | 5096 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2014 | 68 | 0.030 |
Why?
| | RNA, Messenger | 3 | 2009 | 2838 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2014 | 117 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2014 | 139 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2017 | 1061 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 886 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2011 | 1740 | 0.020 |
Why?
| | Transplantation Chimera | 1 | 2012 | 54 | 0.020 |
Why?
| | Caspases | 1 | 2013 | 247 | 0.020 |
Why?
| | Capillaries | 1 | 2012 | 108 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 544 | 0.020 |
Why?
| | Peroxidase | 1 | 2012 | 176 | 0.020 |
Why?
| | Pericytes | 1 | 2011 | 33 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 71 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2014 | 433 | 0.020 |
Why?
| | Albumins | 1 | 2011 | 114 | 0.020 |
Why?
| | Lipopeptides | 1 | 2011 | 13 | 0.020 |
Why?
| | Celecoxib | 1 | 2010 | 39 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 134 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 845 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 153 | 0.020 |
Why?
| | Receptors, Leukotriene B4 | 1 | 2009 | 7 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2011 | 186 | 0.020 |
Why?
| | Lipoproteins | 1 | 2011 | 168 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 386 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 654 | 0.020 |
Why?
| | Biological Transport | 2 | 2004 | 416 | 0.020 |
Why?
| | Acetyltransferases | 1 | 2008 | 22 | 0.020 |
Why?
| | Hemodynamics | 1 | 2013 | 1114 | 0.020 |
Why?
| | Acyltransferases | 1 | 2008 | 56 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 849 | 0.020 |
Why?
| | Heart | 1 | 2012 | 660 | 0.020 |
Why?
| | Cell Count | 2 | 2000 | 321 | 0.020 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2007 | 8 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2007 | 79 | 0.020 |
Why?
| | Acylation | 1 | 2007 | 30 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2010 | 487 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1999 | 1108 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 13243 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2008 | 536 | 0.020 |
Why?
| | Phosphatidylethanolamines | 1 | 2007 | 77 | 0.020 |
Why?
| | Asthma | 1 | 2001 | 2290 | 0.020 |
Why?
| | Rabbits | 2 | 1999 | 792 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2007 | 138 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2007 | 240 | 0.020 |
Why?
| | Oxygen | 1 | 2011 | 943 | 0.020 |
Why?
| | Gene Expression | 1 | 2011 | 1505 | 0.020 |
Why?
| | Membrane Transport Proteins | 1 | 2007 | 163 | 0.020 |
Why?
| | Gene Deletion | 1 | 2007 | 393 | 0.020 |
Why?
| | Lung | 2 | 2012 | 4066 | 0.020 |
Why?
| | Blood Platelets | 2 | 2000 | 405 | 0.010 |
Why?
| | Cell Line | 1 | 2011 | 2852 | 0.010 |
Why?
| | Blood Pressure | 1 | 2012 | 1776 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 10821 | 0.010 |
Why?
| | Goblet Cells | 1 | 2004 | 22 | 0.010 |
Why?
| | Leukopenia | 1 | 2004 | 31 | 0.010 |
Why?
| | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2004 | 4 | 0.010 |
Why?
| | Benzopyrans | 1 | 2004 | 26 | 0.010 |
Why?
| | Sodium-Hydrogen Exchangers | 1 | 2004 | 26 | 0.010 |
Why?
| | Ovalbumin | 1 | 2004 | 183 | 0.010 |
Why?
| | Nebulizers and Vaporizers | 1 | 2004 | 86 | 0.010 |
Why?
| | Guinea Pigs | 1 | 2004 | 162 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 2004 | 300 | 0.010 |
Why?
| | Hyperplasia | 1 | 2004 | 175 | 0.010 |
Why?
| | Microcirculation | 1 | 2004 | 147 | 0.010 |
Why?
| | Endotoxins | 1 | 2004 | 220 | 0.010 |
Why?
| | Adoptive Transfer | 1 | 2004 | 224 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 283 | 0.010 |
Why?
| | Acetylcholine | 1 | 2004 | 186 | 0.010 |
Why?
| | Electric Stimulation | 1 | 2004 | 272 | 0.010 |
Why?
| | Aerosols | 1 | 2004 | 176 | 0.010 |
Why?
| | Biomarkers | 1 | 2014 | 4172 | 0.010 |
Why?
| | Organ Size | 1 | 2004 | 479 | 0.010 |
Why?
| | Blood-Brain Barrier | 1 | 2004 | 142 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 467 | 0.010 |
Why?
| | Trachea | 1 | 2004 | 236 | 0.010 |
Why?
| | Immunoglobulin E | 1 | 2004 | 341 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2004 | 566 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2501 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2004 | 1271 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2004 | 1357 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1775 | 0.010 |
Why?
| | Enzyme Induction | 1 | 2000 | 90 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2000 | 199 | 0.010 |
Why?
| | Adenylyl Cyclases | 1 | 2000 | 87 | 0.010 |
Why?
| | Arachidonate 15-Lipoxygenase | 1 | 2000 | 23 | 0.010 |
Why?
| | Apoptosis | 1 | 2009 | 2557 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 318 | 0.010 |
Why?
| | Isoenzymes | 1 | 2000 | 305 | 0.010 |
Why?
| | Olive Oil | 1 | 1999 | 3 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2004 | 886 | 0.010 |
Why?
| | Waste Management | 1 | 1999 | 10 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2004 | 1987 | 0.010 |
Why?
| | Free Radical Scavengers | 1 | 1999 | 89 | 0.010 |
Why?
| | Bronchi | 1 | 2000 | 261 | 0.010 |
Why?
| | Lipoproteins, LDL | 1 | 1999 | 119 | 0.010 |
Why?
| | Sputum | 1 | 2000 | 311 | 0.010 |
Why?
| | Epoxide Hydrolases | 1 | 1997 | 13 | 0.010 |
Why?
| | Bronchoconstriction | 1 | 1998 | 32 | 0.010 |
Why?
| | Chemotaxis | 1 | 1998 | 131 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1122 | 0.010 |
Why?
| | Thiophenes | 1 | 1997 | 118 | 0.010 |
Why?
| | Perfusion | 1 | 1997 | 212 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1790 | 0.010 |
Why?
| | Binding Sites | 1 | 1997 | 1310 | 0.010 |
Why?
| | Erythrocytes | 1 | 1997 | 693 | 0.010 |
Why?
| | Brain | 1 | 2004 | 2831 | 0.010 |
Why?
| | Adolescent | 1 | 2004 | 21555 | 0.000 |
Why?
| | Aged | 1 | 2000 | 23798 | 0.000 |
Why?
|
|
Zarini's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|